Breton M, Bourbeau K, Cusson J R, Grégoire J, Guévremont C, Labranche S, Milot A, Robert S, St-Laurent M
Economic Research Unit, Benefit Canada, Montreal.
Healthc Manage Forum. 1996 Summer;9(2):44-7. doi: 10.1016/S0840-4704(10)60852-6.
Drug utilization review programs have been recognized as an effective way to control health care spending while maintaining quality services. This article describes the structure, mandate and activities of Quebec's Drug Utilization Review Network. This 112-member network, which represents 45% of health care facilities in the province, was established to promote the optimal utilization of drugs through the provision of support to pharmacology committees, therapeutic committees and pharmacy departments. The network's main role is to coordinate multi-centre drug utilization studies. Future challenges include maintaining member interest and evaluating the clinical and economic impact of the network's efforts.
药物利用审查计划已被公认为是在维持优质服务的同时控制医疗保健支出的有效方式。本文介绍了魁北克药物利用审查网络的结构、职责和活动。这个由112名成员组成的网络代表了该省45%的医疗保健机构,其设立目的是通过向药理学委员会、治疗委员会和药房部门提供支持来促进药物的最佳利用。该网络的主要作用是协调多中心药物利用研究。未来的挑战包括保持成员的兴趣以及评估该网络工作的临床和经济影响。